Multigene panel testing for hereditary breast and ovarian cancers: An analysis of 1303 BRCA-negative Chinese patients

被引：1
|
作者：
Kwong, Ava
Shin, Vivian
Au, Chun Hang
Ho, Cecilia
Chan, Tsun Leung
Ma, Edmond
机构：
[1] Univ Hong Kong, Hong Kong, Peoples R China
[2] Hong Kong Sanat Hosp, Happy Valley, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e13625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13625
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Multigene panel testing for breast cancer patients at high risk for hereditary cancer
    Shin, H-C.
    Yoo, T-K.
    Lee, E.
    Kee, H-B.
    Han, J.
    Kim, Y.
    Moon, H-G.
    Noh, D-Y.
    Han, W.
    ANNALS OF ONCOLOGY, 2016, 27
  • [22] Clinical Impact of Multigene Panel Testing in Patients with a Personal or Family History of Breast or Ovarian Cancer Previously Negative for BRCA1/2 Genes
    Miller, Devon
    Pritzl, Stephanie
    Tess, Angela
    Gooding, Jessica
    Barroilhet, Lisa
    Dubenske, Lori
    Wisinski, Kari
    CANCER RESEARCH, 2024, 84 (09)
  • [23] A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients
    Lincoln, Stephen E.
    Kobayashi, Yuya
    Anderson, Michael J.
    Yang, Shan
    Desmond, Andrea J.
    Mills, Meredith A.
    Nilsen, Geoffrey B.
    Jacobs, Kevin B.
    Monzon, Federico A.
    Kurian, Allison W.
    Ford, James M.
    Ellisen, Leif W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (05): : 533 - 544
  • [24] Multigene panel analysis in breast and ovarian cancer
    Trapp, Elisabeth Katharina
    Speicher, Michael
    Geigl, Jochen B.
    Kolovetsiou-Kreiner, Vassiliki
    Reisinger, Julia
    Haas, Josef
    Petru, Edgar
    Tamussino, Karl
    Pristauz, Gunda
    CANCER RESEARCH, 2020, 80 (04)
  • [25] Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer.
    Kapoor, Nimmi S.
    Curcio, Lisa D.
    Blakemore, Carlee A.
    Bremner, Amy K.
    McFarland, Rachel E.
    West, John G.
    Banks, Kimberly C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [26] Multigene panel testing of triple negative breast cancer patients from Russia
    Abramov, I.
    Ikonnikova, A.
    Korneva, Y.
    Shisterova, O.
    Emelyanova, M.
    Nasedkina, T.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 559 - 559
  • [27] Germline variants detected by multigene panel testing in patients with suspected hereditary breast cancer
    Togashi, Yusa
    Nagahashi, Masayuki
    Kashima, Mina
    Okada, Chiho
    Kinjo, Chinatsu
    Miyazaki, Ayako
    Ueda, Mako
    Tsubamoto, Hiroshi
    Sawai, Hideaki
    Miyoshi, Yasuo
    SURGERY TODAY, 2025,
  • [28] Identification of high and middle penetrance pathogenic variants in patients with hereditary breast/ovarian cancer by multigene panel analysis
    Ryu, Jin-Sun
    Cho, Eun Hae
    Yoon, Kyong-Ah
    Lee, Eun-Gyeong
    Lee, Eun-Sook
    Kong, Sun-Young
    CANCER RESEARCH, 2019, 79 (13)
  • [29] Clinical evaluation of multigene testing for hereditary breast and ovarian cancer
    Ellisen, Leif
    Kurian, Allison
    Lincoln, Stephen
    Desmond, Andrea
    Mills, Meredith
    Shannon, Kristen
    Gabree, Michelle
    Anderson, Michael
    Kobayashi, Yuya
    Monzon, Federico
    Ford, James
    CANCER RESEARCH, 2015, 75
  • [30] Technical evaluation of multigene testing for hereditary breast and ovarian cancer
    Lincoln, Stephen
    Kurian, Allison
    Desmond, Andrea
    Nilsen, Geoffrey
    Jacobs, Kevin
    Yang, Shan
    Hart, Reece
    Monzon, Federico
    Ellisen, Leif
    Ford, James
    CANCER RESEARCH, 2015, 75
12345